Effect of detomidine on visceral and somatic nociception and duodenal motility in conscious adult horses.

This study investigates the effects of detomidine, a sedative and analgesic, on visceral and somatic pain sensations, heart and respiratory rates, sedation levels, and duodenal motion in adult horses. The findings reveal that detomidine significantly reduces heart rate, skin temperature, and respiratory rates, and increases the threshold for distension-related pain in the colorectum and duodenum.

Objective of the Study

The primary goal of the research is to understand the influence of detomidine on visceral and somatic pain sensations, heart and respiration rates, sedation, and duodenal motility in adult horses. It also seeks to establish a correlation between the effects observed and serum concentrations of detomidine.

Methodology

• The study was a non-random experimental trial involving five adult horses.
• Each of these horses was equipped with a permanent gastric cannula and weighed around 534 +/- 46 kg.
• Pain perception was assessed via colorectal (CRD) and duodenal distension (DD), and somatic pain was determined by thermal threshold (TT).
• Sedation was measured by the distance between the horse’s nose and the ground (NTG).
• Pharmacokinetic analysis was performed on the collected serum, and detomidine was administered intravenously at either 10 or 20 micrograms per kilogram.
• The data collected was analyzed using a three-factor anova, and statistical significance was determined at p < 0.05.

Findings of the Study

• Detomidine led to a dose-dependent reduction in NTG height, heart rate, and skin temperature. This indicates increased sedation and decreased physiological activity.
• Colorectal distension threshold increased significantly for 15 minutes at 10 micrograms per kilogram detomidine dose and for at least 165 minutes at 20 micrograms per kilogram detomidine dose. This shows that detomidine reduces gastrointestinal pain sensation in a dose-dependent manner.
• Duodenal distension threshold increased significantly at 15 minutes for high detomidine dose, indicating the drug’s positive impact on reducing duodenal pain.
• Lack of effect on TT suggests detomidine doesn’t affect somatic pain sensation. This may be due to vasoconstriction activity and low thermal cut-off of the testing device.
• Detomidine administration caused a marked decrease in duodenal contractions, indicating a possible slowing down of gut motility.

Conclusion

Detomidine was observed to have a significant effect on visceral anti-nociception duration, heart and respiratory rates, and duodenal motility, but less impact on somatic anti-nociception. The discrepancies in different types of pain perception may be linked to the physiological effects of the drug, such as peripheral vasoconstriction and decreased skin temperature.